Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:31PM EST. Market open.
Loading interactive chart…
- Zacks
Biogen (BIIB) to Sell Biosimilar JV Stake to Samsung Biologics
Biogen (BIIB) is selling its equity stake in the Samsung Bioepis joint venture to partner Samsung Biologics
- Bloomberg
Biogen Sells Bioepis Stake for $2.3 Billion to Samsung Biologics
(Bloomberg) -- Samsung Biologics Co. will buy 49.9% of Samsung Bioepis from Biogen Inc., according to a regulatory filing, giving the South Korean drugmaker full ownership of the joint venture. Most Read from BloombergApple to Rival Square by Turning iPhones Into Payment TerminalsStocks Drop in Roller-Coaster Ride for Wall Street: Markets WrapCrypto Secrecy Makes DeFi a Financial Felon’s WonderlandHow a Fox News Interview Threw the Antiwork Subreddit Into ChaosAmericans’ Gas Stoves Are as Bad fo
© 2022 Yahoo. All rights reserved.
